Illumina, Inc.
ILMN
Clasificación en acciones
#617
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Precio por acción
$262.32
Última sincronización: 2026-10-16
Capitalización bursátil
$39.61B
Cambio (1 día)
-2.09%
Cambio (1 año)
174.80%
País
US
Comercio Illumina, Inc. (ILMN)
Categoría
Healthcare
EPS de Illumina, Inc. (ILMN)
EPS a fecha de June 2026 TTM: $5.41
Según los últimos informes financieros y el precio de las acciones de Illumina, Inc., el EPS actual de la empresa (TTM) es $5.41. Al final del año 2024, la empresa tenía un EPS de $-7.69 un aumento con respecto a al EPS de 2023, que fue de $-7.35.
Historial de EPS de Illumina, Inc. desde 2000 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $5.41 | -1.10% |
| 2025 | $5.47 | -171.13% |
| 2024 | $-7.69 | 4.63% |
| 2023 | $-7.35 | -244.69% |
| 2022 | $5.08 | 13.90% |
| 2021 | $4.46 | -34.60% |
| 2019 | $6.82 | 21.35% |
| 2018 | $5.62 | 13.08% |
| 2017 | $4.97 | 57.78% |
| 2016 | $3.15 | -0.94% |
| 2015 | $3.18 | 21.84% |
| 2014 | $2.61 | 161.00% |
| 2013 | $1.00 | -18.70% |
| 2012 | $1.23 | 75.71% |
| 2011 | $0.70 | -30.69% |
| 2010 | $1.01 | 71.19% |
| 2009 | $0.59 | 37.21% |
| 2008 | $0.43 | -116.73% |
| 2007 | $-2.57 | -671.11% |
| 2006 | $0.45 | -273.08% |
| 2005 | $-0.26 | 199.54% |
| 2004 | $-0.09 | -79.33% |
| 2003 | $-0.42 | -35.38% |
| 2002 | $-0.65 | 54.76% |
| 2001 | $-0.42 | 27.27% |
| 2000 | $-0.33 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $18.62 | 244.18% |
US
|
|
| $5.65 | 4.44% |
US
|
|
| $-1.36 | -125.14% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -5.91% |
US
|
